Pregnancy Complications - A Probiotic Interventional Study

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions
PreeclampsiaPreterm Birth
Interventions
DRUG

probiotic

Low-risk women, women with prior preeclampsia and women with a prior preterm birth will be randomized to be treated with LGG during pregnancy. Effect on maternal and perinatal outcome as well as the effect of treatment on immunological and inflammatory biomarkers will be evaluated.

DRUG

placebo

Low-risk women, women with prior preeclampsia and women with a prior preterm birth will be randomized to be treated with placebo during pregnancy. Effect on maternal and perinatal outcome as well as the effect of treatment on immunological and inflammatory biomarkers will be evaluated.

Trial Locations (1)

416 85

Bo Jacobsson, Gothenburg

All Listed Sponsors
lead

Sahlgrenska University Hospital

OTHER

NCT02693041 - Pregnancy Complications - A Probiotic Interventional Study | Biotech Hunter | Biotech Hunter